Improving the lives of patients with chronic diseases: Pharmacists as a solution

Journal of Health Care for the Poor and Underserved

Volumn 22, Issue 2, 2011, Pages 429-436

  de Bittner, Magaly Rodriguez ^a   Zaghab, Roxanne Ward ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b NONE

Author keywords

Chronic disease management; Drug safety; Medication therapy management; Pharmacists

Indexed keywords

ARTICLE; CHRONIC DISEASE; DRUG TOXICITY; HUMAN; HUMAN RELATION; PATIENT COMPLIANCE; PHARMACIST; PROFESSIONAL STANDARD; PUBLIC RELATIONS; QUALITY OF LIFE; TREATMENT OUTCOME;

CHRONIC DISEASE; DRUG TOXICITY; HUMANS; INTERPROFESSIONAL RELATIONS; MEDICATION ADHERENCE; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 80051604146     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2011.0044     Document Type: Article

References (36)

1. Dingham J, Glenn ZM, Leal S. Improving patient safety-improving lives: a patient's story. J Health Care Poor Underserved. 2009 Feb; 20(1):1-3.
2. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999. Available at: http://www.providersedge.com/ehdocs/ehr_articles/To_Err_Is_Human_%20Building_a_Safer_Health_System-exec_summary.pdf.
3. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001 Mar-Apr; 41(2):192-199.
4. New England Healthcare Institute. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. Cambridge, MA: New England Healthcare Institute, 2009 Aug. Available at: http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease.
5. Wu S, Green A. Projection of chronic illness prevalence and cost inflation. Santa Monica, CA: RAND Corporation, 2000.
6. American College of Physicians. Solutions to the challenges facing primary care medicine: comprehensive strategies from the American College of Physicians. Phila delphia, PA: American College of Physicians Policy Monograph, 2009. Available at: http://www.acponline.org/advocacy/where_we_stand/policy/solutions.pdf.
7. American Association of Medical Colleges. Physician shortages to worsen without increases in residency training. Washington, DC: American Association of Medical Colleges. 2010 Sep. Available at: https://www.aamc.org/download/150584/data/physician_shortages_to_worsen_without_increases_in_residency_tr.pdf.
8. Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Sys Pharm. 1999 Jul;56(14):1405-1426.
9. McHorney CA. The adherence estimator: a brief proximal screener for patient propensity to adhere to prescription medications for chronic disease. Cur Med Res Opin. 2009 Jan;25(1):215-38.
10. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007 Mar;167(6): 540-50.
11. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004 May;27(5):1218-24.
12. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001 Dec;54 Suppl 1:S57-60.
13. Rodriguez de Bittner M, Maryland Board of Pharmacy. Drug therapy management report on the study to access the outcomes achieved by drug therapy management agreements to the General Assembly. Baltimore, MD: Maryland Board of Pharmacy/ Maryland General Assembly, 2010 Jan 1. Available at: http://www.dhmh.state.md.us/reports/pdf/2009/dec09/pharm/HB0781_Pharm_Therapy%20Mgmt%20Contracts.pdf.
14. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006 Dec;296(21):2563-71.
15. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007 May;146(10): 714-25.
16. Bailey SC, Pandit AU, Curtis L, et al. Availability of Spanish prescription labels: a multi-state pharmacy survey. Med Care. 2009 Jun;47(6):707-10.
17. Sharif I, Lo S, Ozuah PO. Availability of Spanish prescription labels. J Health Care Poor Underserved. 2006 Feb;17(1):65-9.
18. Betacourt JR. Cultural competency: providing quality care to diverse populations. Consult Pharm. 2006 Dec;21(2):988-95.
19. Quist RM, Law AV. Proposed model. Cultural competency: agenda for cultural competency using literature and evidence. Res Soc Admin Pharm. 2006 Sep;2(3):420-38.
20. Flores G. The impact of medical interpreter services on the quality of health care: a systematic review. Med Care Res Rev. 2005 Jun;62(3):255-99.
21. Bradshaw M, Tomany-Korman S, Flores G. Language barriers to prescriptions for patients with limited English language proficiency: a survey of pharmacists. Pediatrics. Aug 2007;120(2):e225-35.
22. Rodriguez de Bittner, M. Applying cultural competency skills to patient self-care and self-management. Presented at: American Society of Health System Pharmacists Annual Meeting, Las Vegas, NV, 2005 Dec.
23. Shaya FT, Gbarayor CM. The case for cultural competence in health professions education. Am J Pharm Educ. 2006 Dec;70(6):124-31.
24. U.S. Department of Labor/Bureau of Labor Statistics. Occupational outlook handbook: pharmacists (2010-2011 edition). Washington, DC: Bureau of Labor Statistics. Available at: http://www.bls.gov/oco/ocos079.htm.
25. Gallup Inc. Honesty/ethics in professions. Washington, DC: Gallup Inc, 2009 Nov. Available at: http://gallup.com/poll/1654/honesty-ethics-professionas.aspx.
26. Smedley BD, Stith AY, Nelson AR, eds. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academy Press, 2003.
27. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996 Apr;100(4):428-37.
28. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Sys Pharm. 2002 Nov;59(21):2089-92.
29. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):173-84.
30. Amour BL, Britton ML, Dennis VC, et al. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010 Jun;23(3):250-64.
31. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interactions to reduce risk behaviors and risk factors for coronary heart disease. J Public Health Med. 2003 Jun;25(2):144-53.
32. Fera T, Bluml BM, Ellis WM, et al. The diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc. 2008 Mar-Apr;48(2):181-90.
33. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009 May-Jun;49(3):383-91.
34. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care. 2007 Jan; 30 Suppl 1:S4-S41.
35. Rochester CD, Leon N, Dombrowski R, et al. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2010 Jan;67(1):42-8.
36. Carmichael JM, O'Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy. 1997;17(5);1050-61. Available at: http://www.accp.com/docs/positions/positionStatements/pos19.pdf.